Literature DB >> 33134207

Hemophagocytic lymphohistiocytosis syndrome associated with Epstein-Barr infection in an immunocompetent patient. A case study.

Petros Ioannou1, Evangelia Akoumianaki2, Konstantinos Alexakis3, Athanasia Proklou2, Maria Psyllaki4, Efthimis Stamatopoulos5, Mairi Koulentaki6, Eumorfia Kondili2, Diamantis P Kofteridis7.   

Abstract

INTRODUCTION: Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening rare disease resulting from the uncontrolled activation of the immune system, leading to unrestrained cytokine release and macrophage activation. It can be either hereditary or acquired due to infections, hematological disease or malignancy. CASE REPORT: We present the case of a 19-year old woman that presented with high fever and acute cholestatic hepatitis. She was initially admitted to the Gastroenterology department and the following days she developed respiratory distress and multiorgan insufficiency that necessitated intubation and support in the Intensive Care Unit. Fever, splenomegaly, hypertriglyceridemia, increased ferritin levels and hemophagocytosis in the bone marrow were found, thus, fulfilling the criteria of hemophagocytic lymphohistiocytosis. Laboratory examination was notable for positive serology (IgM and IgG) and PCR for EBV in the serum. An extensive workup including virology and immunologic workup, blood cultures, a CT of the thorax and the abdomen and a bone marrow biopsy did not reveal any cause of secondary HLH other than the EBV infection. The patient was treated with high dose corticosteroids and intravenous immunoglobulins with slow resolution of her symptoms.
CONCLUSIONS: In patients with EBV infection who exhibit persistent high fever and unresponsiveness to antibiotics, the possibility of HLH should be considered. Early diagnosis and rapid initiation of appropriate treatment may avert an unfavorable outcome. GERMS.

Entities:  

Keywords:  EBV; Epstein-Barr; Hemophagocytic lymphohistiocytosis; macrophage activation syndrome

Year:  2020        PMID: 33134207      PMCID: PMC7572213          DOI: 10.18683/germs.2020.1216

Source DB:  PubMed          Journal:  Germs        ISSN: 2248-2997


  16 in total

Review 1.  [Intravenously administered gamma-globulins in reactive hemaphagocytic syndrome. Multicenter study to assess their importance, by the immunoglobulins group of experts of CEDIT of the AP-HP].

Authors:  C Larroche; F Bruneel; M H André; B Bader-Meunier; A Baruchel; B Tribout; T Genereau; P Zunic
Journal:  Ann Med Interne (Paris)       Date:  2000-11

2.  Intravenous immunoglobulin for hemophagocytic lymphohistiocytosis?

Authors:  Urban Emmenegger; Peter J Spaeth; Klaus A Neftel
Journal:  J Clin Oncol       Date:  2002-01-15       Impact factor: 44.544

3.  HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis.

Authors:  Jan-Inge Henter; Annacarin Horne; Maurizio Aricó; R Maarten Egeler; Alexandra H Filipovich; Shinsaku Imashuku; Stephan Ladisch; Ken McClain; David Webb; Jacek Winiarski; Gritta Janka
Journal:  Pediatr Blood Cancer       Date:  2007-02       Impact factor: 3.167

4.  Successful treatment of cytomegalovirus-associated hemophagocytic syndrome by intravenous immunoglobulins.

Authors:  Arnaud Hot; Marie Hélène Girard Madoux; Jean P Viard; Brigitte Coppéré; Jacques Ninet
Journal:  Am J Hematol       Date:  2008-02       Impact factor: 10.047

Review 5.  How I treat hemophagocytic lymphohistiocytosis in the adult patient.

Authors:  Alison M Schram; Nancy Berliner
Journal:  Blood       Date:  2015-03-10       Impact factor: 22.113

6.  Epstein Barr virus hepatitis.

Authors:  Diamantis P Kofteridis; Mairi Koulentaki; Antonios Valachis; Maria Christofaki; Elias Mazokopakis; George Papazoglou; George Samonis
Journal:  Eur J Intern Med       Date:  2010-08-19       Impact factor: 4.487

7.  Clinical characteristics, prognostic factors, and outcomes of adult patients with hemophagocytic lymphohistiocytosis.

Authors:  Zaher K Otrock; Charles S Eby
Journal:  Am J Hematol       Date:  2015-01-16       Impact factor: 10.047

8.  Recommendations for the management of hemophagocytic lymphohistiocytosis in adults.

Authors:  Paul La Rosée; AnnaCarin Horne; Melissa Hines; Tatiana von Bahr Greenwood; Rafal Machowicz; Nancy Berliner; Sebastian Birndt; Juana Gil-Herrera; Michael Girschikofsky; Michael B Jordan; Ashish Kumar; Jan A M van Laar; Gunnar Lachmann; Kim E Nichols; Athimalaipet V Ramanan; Yini Wang; Zhao Wang; Gritta Janka; Jan-Inge Henter
Journal:  Blood       Date:  2019-04-16       Impact factor: 22.113

9.  Epstein-barr virus latent membrane protein-1 mediates upregulation of tumor necrosis factor-alpha in EBV-infected T cells: implications for the pathogenesis of hemophagocytic syndrome.

Authors:  Jong-Ding Lay; Shuang-En Chuang; Martin Rowe; Ih-Jen Su
Journal:  J Biomed Sci       Date:  2003 Jan-Feb       Impact factor: 8.410

Review 10.  Hemophagocytic lymphohistiocytosis: review of etiologies and management.

Authors:  Melissa R George
Journal:  J Blood Med       Date:  2014-06-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.